Scale -

  • Ebitda is 1034 Rs Cr; Annual Growth is 23 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 26 %
  • PBT is 302 Rs Cr; Annual Growth is 16 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 26 %
  • Revenue is 5090 Rs Cr; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 13 %
  • Quarterly Revenue is 1423 Rs Cr; Continuous Growth over 3 Quarters; in Top Quartile
  • Quarterly Profit is 233 Rs Cr; Continuous Growth over 3 Quarters; in Top Quartile

Profitability -

  • Quarterly Profit margin is 16 %; Continuous Growth over 3 Quarters; in Top Quartile
  • PBDIT Margin is 20.32 %; 5 Year CAGR is 11 %
  • PAT Margin is 10.26 %; Continuous Decline over 3 years
  • Quarterly Ebitda Margin is 17 %; Continuous Decline over 3 Quarters

Return -

  • ROCE is 49.27 %; Annual Growth is 24 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 36 %
  • ROA is 16.64 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 19 %
  • ROE is 29.54 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 29 %
  • Asset Turnover is 165 %; Continuous Growth over 3 years

Efficiency -

  • Operating cash flow is 514 Rs Cr; Annual Growth is 45 %; in Top Quartile
  • Inventory Turnover Ratio is 6.92; 5 Year CAGR is 24 %
  • Current Ratio is 2.18; Continuous Decline over 3 years
  • Quick Ratio is 1.48; Continuous Decline over 3 years

Solvancy -

  • Contingent Liabilities is 321 Rs Cr; Annual Decline is -43 %; Continuous Decline over 3 years; in Top Quartile
  • Debt/Equity is 0; in Bottom Quartile
  • Total Debt is 0 Rs Cr; in Bottom Quartile

Quality -

  • Operating cashflow/PAT is 98 %; Annual Growth is 32 %
  • Change in Inventories/Total Expenses is -2 %; Continuous Decline over 3 years; in Bottom Quartile
  • Current Tax/PAT is 72 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 19 %
  • Other Expenses/Total Expenses is 16 %; Continuous Growth over 3 years

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem

Sector
Major Subsidiaries/Associates
Key Clients

Products

Products
Product details

Operations

Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
Strides Pharma Science appoints Biren Gabhawala as independent director
Read More
  • Past/current